158 related articles for article (PubMed ID: 2351647)
1. Activation of human platelets by a stimulatory monoclonal antibody.
Kornecki E; Walkowiak B; Naik UP; Ehrlich YH
J Biol Chem; 1990 Jun; 265(17):10042-8. PubMed ID: 2351647
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor.
Naik UP; Ehrlich YH; Kornecki E
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):155-62. PubMed ID: 7646439
[TBL] [Abstract][Full Text] [Related]
3. Stimulatory antibody-induced activation and selective translocation of protein kinase C isoenzymes in human platelets.
Wang F; Naik UP; Ehrlich YH; Osada S; Ohno S; Kornecki E
Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):401-6. PubMed ID: 7487874
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
5. Anti-GPIIb/IIIa (CD41) monoclonal antibody-induced platelet activation requires Fc receptor-dependent cell-cell interaction.
Anderson GP; van de Winkel JG; Anderson CL
Br J Haematol; 1991 Sep; 79(1):75-83. PubMed ID: 1832937
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fibrin(ogen) binding to stimulated platelets by a monoclonal antibody specific for a conformational determinant of GPIIIa.
Ramsamooj P; Doellgast GJ; Hantgan RR
Thromb Res; 1990 Jun; 58(6):577-92. PubMed ID: 2385828
[TBL] [Abstract][Full Text] [Related]
7. Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (Fc gamma RII).
Rubinstein E; Kouns WC; Jennings LK; Boucheix C; Carroll RC
Br J Haematol; 1991 May; 78(1):80-6. PubMed ID: 1828363
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways of the F11 receptor (F11R; a.k.a. JAM-1, JAM-A) in human platelets: F11R dimerization, phosphorylation and complex formation with the integrin GPIIIa.
Sobocka MB; Sobocki T; Babinska A; Hartwig JH; Li M; Ehrlich YH; Kornecki E
J Recept Signal Transduct Res; 2004 Feb; 24(1-2):85-105. PubMed ID: 15344881
[TBL] [Abstract][Full Text] [Related]
9. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa.
Christopoulos C; Mackie I; Lahiri A; Machin S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):729-37. PubMed ID: 8292722
[TBL] [Abstract][Full Text] [Related]
12. Activation of human platelets by exposure to a monoclonal antibody, PM6/248, to glycoprotein IIb-IIIa.
Hornby EJ; Brown S; Wilkinson JM; Mattock C; Authi KS
Br J Haematol; 1991 Oct; 79(2):277-85. PubMed ID: 1958486
[TBL] [Abstract][Full Text] [Related]
13. Preferred use of primary radiolabeled anti-platelet monoclonal antibodies. Comparison of immunoblotting methods for the analysis of functional domains on human platelets.
Walkowiak B; Naik UP; Lange M; Kornecki E
Thromb Res; 1992 Dec; 68(4-5):323-31. PubMed ID: 1290162
[TBL] [Abstract][Full Text] [Related]
14. Effects of a monoclonal antibody to glycoprotein IIb/IIIa (P256) and of enzymically derived fragments of P256 on human platelets.
Stuttle AW; Powling MJ; Ritter JM; Hardisty RM
Thromb Haemost; 1991 Apr; 65(4):432-7. PubMed ID: 2057927
[TBL] [Abstract][Full Text] [Related]
15. Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion.
Babinska A; Kedees MH; Athar H; Sobocki T; Sobocka MB; Ahmed T; Ehrlich YH; Hussain MM; Kornecki E
Thromb Haemost; 2002 Apr; 87(4):712-21. PubMed ID: 12008956
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a platelet membrane protein of low molecular weight associated with platelet activation following binding by monoclonal antibody AG-1.
Miller JL; Kupinski JM; Hustad KO
Blood; 1986 Sep; 68(3):743-51. PubMed ID: 2943333
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-platelet interactions and platelet fibrinogen receptor exposure.
Kornecki E; Ehrlich YH; Egbring R; Gramse M; Seitz R; Eckardt A; Lukasiewicz H; Niewiarowski S
Am J Physiol; 1988 Sep; 255(3 Pt 2):H651-8. PubMed ID: 3414826
[TBL] [Abstract][Full Text] [Related]
18. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction.
Mazurov AV; Vinogradov DV; Vlasik TN; Repin VS; Booth WJ; Berndt MC
Thromb Res; 1991 Jun; 62(6):673-84. PubMed ID: 1718052
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa.
Kornecki E; Tuszynski GP; Niewiarowski S
J Biol Chem; 1983 Aug; 258(15):9349-56. PubMed ID: 6308003
[TBL] [Abstract][Full Text] [Related]
20. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
